The impact of inhaler on the environment and climate change: past, present, and future
Postgraduate Medical Journal · 23.01.2026 · 102 (1204) · 109-111
DOI: 10.1093/postmj/qgaf121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Postgraduate Medical Journal, online erschienen am 04.08.2025. Verfasst von Elizabeth Man Chin Ng und 1 weiteren Autor:innen. Beteiligte Einrichtung: Tuberculosis and Chest Unit, Grantham Hospital, 125 Wong Chuk Hang Road, Aberdeen, Hong Kong SAR, 999077, China. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
Asthma and chronic obstructive pulmonary disease (COPD) are two of the most prevalent chronic respiratory conditions, affecting an estimated 262 million and 391 million people globally, respectively. Together, they contribute to over 3.5 million deaths annually, with COPD ranking as the third leading cause of death worldwide [1]. Inhaled therapy is the cornerstone of treatment for asthma and COPD, offering quick, targeted relief without systemic side effects. However, this mainstay of management is increasingly under scrutiny, not only for clinical concerns, but also for its environmental impact. Misdiagnosis of asthma and COPD is another issue at hand, with studies showing up to 30%–33% of asthma diagnoses may be inaccurate, leading to over-prescription of inhalers and unnecessary environmental harm [2]. Meanwhile, suboptimal disease control often results in short-acting beta-agonist overuse, which subsequently increases carbon footprint. In particular, pressurized metered-dose inhalers (pMDIs) that are popular among COPD patients due to its effective drug delivery through generating sufficient inspiratory flow, uses chlorofluorocarbons (CFCs) propellants, potent greenhouse gases with global warming potentials (GWPs) 1300 times greater than carbon dioxide. A single pMDI can have a carbon footprint equivalent to a 290-km car journey. In the UK, inhalers account for ~3% of the National Health Service’s total carbon footprint. Furthermore, an Australian study suggested that inpatient pMDI use significantly outweighed that of dry powder inhalers (DPIs) and soft mist inhalers and accounted for ~99% of inhaler-related greenhouse gas emissions in Melbourne hospital [3].
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Tuberculosis and Chest Unit, Grantham Hospital, 125 Wong Chuk Hang Road, Aberdeen, Hong Kong SAR, 999077, China.
- Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong SAR, 999077, China.
ORCID-Profile: Wang Chun Kwok
Zitieren
APA
Ng, E. M. C., & Kwok, W. C. (2026). The impact of inhaler on the environment and climate change: past, present, and future. Postgraduate Medical Journal, 102(1204), 109-111. https://doi.org/10.1093/postmj/qgaf121
Vancouver
Ng EMC, Kwok WC. The impact of inhaler on the environment and climate change: past, present, and future. Postgraduate Medical Journal. 2026;102(1204):109-111. doi:10.1093/postmj/qgaf121
BibTeX
@article{Ng2026,
author = {Ng, Elizabeth Man Chin and Kwok, Wang Chun},
title = {The impact of inhaler on the environment and climate change: past, present, and future},
journal = {Postgraduate Medical Journal},
year = {2026},
volume = {102},
number = {1204},
pages = {109--111},
doi = {10.1093/postmj/qgaf121}
}
EUVIMED